Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 17 Mar 2023
Germany: Activation of bitter taste receptors opens lung pathways, making them potential targets for the treatment of chronic lung diseases...
Read Full NewsPeople with lower limb motor disability need tailored equipment, training, and medical oversight to boost performance while preventing upper limb overload and skin problems.
Nearly half of maternal deaths from venous thromboembolism in France over 12 years were preventable.
Nearly half of new colorectal cancer cases now occur in people younger than age 65 years, highlighting the need for earlier screening and better symptom awareness.
Tight glycemic targets in gestational diabetes can lower the risk for large-for-gestational-age births without increasing the risk for serious maternal and neonatal complications.
1.
Pediatric high-grade gliomas: Research reveals effective targeting with avapritinib
2.
Promising Results With Epcoritamab Monotherapy in Relapsed/Refractory CLL
3.
Coffee and tea linked to lower head and neck cancer risk
4.
For patients with breast cancer receiving chemotherapy, exercise may help lessen the long-term side effects.
5.
Can taking vitamin D supplements every day lower the mortality rate from cancer?
1.
Demystifying Hematoma Rectus Sheath: Knowing the Symptoms and Causes
2.
Effective Management Strategies for Sickle Cell Crisis: Insights from Medical Experts
3.
What Is Carboxyhemoglobin And How Can It Affect Your Health?
4.
Advancements in Cancer Treatment Strategies for Non-Hodgkin Lymphoma
5.
Survivin as a Key Regulator in Gynecological Cancers: Therapeutic and Prognostic Implications
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
3.
Managing CNS diseases at the point of diagnosis in ALK + NSCLC
4.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion
5.
Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge